Skip to main content
Caplight Logo









GeneFluidics, Inc.

GeneFluidics, Inc.

Private
Irwindale, CaliforniaHealthcare & Life Scienceshttps://genefluidics.com

Last Round

Series A

Nov 4, 2022

Total Funding Raised

$15.78M

Company Overview

GeneFluidics, Inc. is a biotechnology company that develops rapid molecular diagnostic platforms for the detection of infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

molecular diagnosticsmicrofluidicsantimicrobial susceptibility testingASTpathogen identificationelectrochemical sensorslab-on-a-chippoint-of-care diagnosticsPOC testingrobotic lab automationbiosensorsrazor-and-blade modelinfectious disease testingmedical deviceclinical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GeneFluidics, Inc. Comparables

Compare GeneFluidics, Inc. with similar companies based on industry and business-model similarity.

GeneFluidics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Avails Medical
80%
Pattern Bioscience
80%
QuantaMatrix Inc.
79%

GeneFluidics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 4, 2022
GrantSep 30, 2021
GrantSep 30, 2020
GrantSep 30, 2019
GrantSep 30, 2018
Grant
Sep 30, 2017

GeneFluidics, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 4, 2022

    Raised Series A round with Bradbury Asset Management.

  • Sep 30, 2021

    $962K grant received from U.S. Department of Health and Human Services.

GeneFluidics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GeneFluidics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GeneFluidics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersIrwindale, California
Employee Range2
Year Founded2000
Last FundingNov 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?